TMO
Thermo Fisher Scientific Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$608.30
−1.64%Leverage
- Debt / equity
- 0.81x
- Net debt / equity
- 0.73x
- Debt / assets
- 0.38x
- Debt / EBITDA
- 3.89x
- Net debt / EBITDA
- 3.52x
Liquidity & coverage
- Current ratio
- 1.55x
- Quick ratio
- 1.18x
- Cash ratio
- 0.27x
- Interest coverage
- 5.59x
- EBITDA / interest
- 7.45x
- Working capital
- $8.3B
Cash & dividend
- FCF / debt
- 0.17x
- Cash flow / debt
- 0.21x
- Dividend per share
- $0.94
- Dividend yield
- 0.2%
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026